Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery

Journal of Controlled Release

Volumn 78, Issue 1-3, 2002, Pages 235-247

  Lestini, Brian J ^a   Sagnella, Sharon M ^a   Xu, Zhong ^a   Shive, Matthew S ^b   Richter, Nancy J ^a   Jayaseharan, Johnsamuel ^a   Case, Aubrey J ^a   Kottke Marchant, Kandice ^c   Anderson, James M ^b   Marchant, Roger E ^a  

^a Case Western Reserve University   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiovascular drug delivery; Liposomes; Oligosaccharides; Peptides; Targeting

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CELL SURFACE RECEPTOR; DEXTRAN; DRUG CARRIER; FIBRINOGEN RECEPTOR; INTEGRIN; LIPOSOME; SURFACTANT;

BINDING AFFINITY; CARDIOVASCULAR DISEASE; CELL VACUOLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG RECEPTOR BINDING; GEOMETRY; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; TARGET CELL; THROMBOCYTE ACTIVATION;

ANIMALS; CARDIOVASCULAR DISEASES; DEXTRANS; DRUG DELIVERY SYSTEMS; FEMALE; LIPOSOMES; MICE; MICE, INBRED BALB C; OLIGOPEPTIDES; OLIGOSACCHARIDES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 0037122697     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00505-3     Document Type: Conference Paper

References (41)

1. Acute platelet inhibition with abciximab does not reduce in-stent restenosis (ERASER study)
2. Update on pharmacology for restenosis
3. Low molecular mass heparin in prevention of restenosis after angioplasty. Results of enoxaparin restenosis (ERA) trial
4. Nanoparticle drug delivery system for restenosis
5. Local drug delivery for the prevention of restenosis
6. Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization
7. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
8. Nanoparticulate delivery system of a tyrophostin for the treatment of restenosis
9. The effect of intramural delivery of polymeric nanoparticles loaded with the antiproliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary arteries
10. Local irrigation with tissue factor pathway inhibitor inhibits intimal hyperplasia induced by arterial interventions
11. Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis
12. Poly(ethylene glycol) on the liposome surface: On the mechanism of polymer-coated liposome longevity
13. Controlling liposome blood clearance by surface-grafted polymers
14. 3 and elicit different functional responses
15. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids
16. Integrin-dependent interaction of human vascular endothelial cells on biomimetic peptide surfactant polymers
17. Novel polysaccharide surfactants: The effect of hydrophobic and hydrophilic chain length on surface active properties
18. Ligand-targeted liposomes
19. Proteins and peptides bound to long-circulating liposomes
20. Mechanisms involved in the inhibition of neointimal hyperplasia by abciximab in a rat model of balloon angioplasty
21. Role of platelets in restenosis after percutaneous coronary revascularization
22. 3 subunit: Cation displacement is involved in ligand binding
23. Intrahepatic distribution of long-circulating liposomes containing poly(ethylene glycol) distearoyl phosphatidylethanolamine
24. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy
25. Molecular mechanism of the lipid vesicle longevity in vivo
26. Experimental and Monte Carlo simulation studies of the thermodynamics of polyethylene glycol chains grafted to lipid bilayers
27. Large unilamellar liposomes with low uptake into the reticuloendothelial system
28. Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions
29. Enhancement of the in vivo circulation lifetime of L-α-distearoylphosphatidylcholine liposomes: Importance of liposomal aggregation versus complement opsonization
30. Biomimetic engineering of non-adhesive glycocalyx-like surfaces using oligosaccharide surfactant polymers
31. Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups
32. Pharmacokinetics of long-circulating liposomes
33. 1-containing liposomes
34. Modulation of pharmacokinetic behavior of liposomes
35. Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation lifetimes
36. Liposome disposition in vivo: III. Dose and vesicle-size effects
37. Correlation of membrane/water coefficients of detergents with the critical micelle concentration
38. Lipid/detergent interaction thermodynamics as a function of molecular shape
39. Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers